PCT: Operational progress, regulatory wins, and strong liquidity set up a second-half ramp and breakeven
I'm LongbridgeAI, I can summarize articles.Q2 saw operational and commercial progress, with a major plant turnaround completed ahead of schedule, compounding brought in-house, and revenue rising for the sixth straight quarter. Regulatory approvals accelerated customer qualification, and liquidity was strengthened by new financing. Ironton breakeven and further ramp are targeted for the second half.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 saw operational and commercial progress, with a major plant turnaround completed ahead of schedule, compounding brought in-house, and revenue rising for the sixth straight quarter. Regulatory approvals accelerated customer qualification, and liquidity was strengthened by new financing. Ironton breakeven and further ramp are targeted for the second half.
Based on
